• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by IGM Biosciences, Inc.

IGM Biosciences to Present at Three Upcoming Investor Conferences
November 04, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Strategic Pivot to Focus Exclusively on Autoimmunity
September 30, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
September 10, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
August 14, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Jefferies Healthcare Conference
May 29, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
May 08, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
May 07, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Refocusing of Sanofi Collaboration
April 17, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
April 10, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
March 07, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
February 01, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the 42nd Annual J.P. Morgan Healthcare Conference
January 03, 2024
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Strategic Pipeline Prioritization and Cash Runway Extension
December 05, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Third Quarter 2023 Financial Results
November 13, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at Two Upcoming Investor Conferences
November 07, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Retirement of Chairman Michael Loberg, Ph.D. from Board of Directors and Appointment of Elizabeth H.Z. Thompson, Ph.D. to Board of Directors
October 03, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
September 06, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Second Quarter 2023 Financial Results
August 03, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Announces Closing of Upsized Public Offering and Concurrent Private Placement and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
July 03, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Announces Pricing of $107.3 Million Upsized Public Offering and Concurrent Private Placement
June 22, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Announces Proposed Public Offering and Concurrent Private Placement
June 21, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Update on IGM-8444 Phase 1 Trial and Future Clinical Development
June 02, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Jefferies Healthcare Conference
June 01, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces FDA Clearance to Begin Clinical Studies of Imvotamab in Lupus and Rheumatoid Arthritis
May 31, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Host Conference Call and Webcast to Provide IGM-8444 Clinical Update
May 30, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces First Quarter 2023 Financial Results and Provides Corporate Update
May 12, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at Two Upcoming Investor Conferences
May 02, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences to Present at the Stifel 2023 Targeted Oncology Days
April 19, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Six Presentations at the American Society for Cancer Research Annual Meeting 2023
April 13, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
IGM Biosciences Announces Fourth Quarter and Full Year 2022 Financial Results and Provides Corporate Update
March 30, 2023
From IGM Biosciences, Inc.
Via GlobeNewswire
Tickers IGMS
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap